tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Repligen price target raised to $175 from $160 at Barclays
PremiumThe FlyRepligen price target raised to $175 from $160 at Barclays
2M ago
Repligen Corporation Reports Strong Q3 2025 Results
Premium
Company Announcements
Repligen Corporation Reports Strong Q3 2025 Results
2M ago
Repligen’s Strong Performance and Strategic Growth Initiatives Earn ‘Buy’ Rating
Premium
Ratings
Repligen’s Strong Performance and Strategic Growth Initiatives Earn ‘Buy’ Rating
2M ago
Novo Nordisk update raises questions on Repligen approval, says Canaccord
PremiumThe FlyNovo Nordisk update raises questions on Repligen approval, says Canaccord
2M ago
Repligen price target raised to $160 from $150 at Barclays
Premium
The Fly
Repligen price target raised to $160 from $150 at Barclays
3M ago
Repligen’s Growth Potential: A Buy Rating Backed by Innovation and Strategic Positioning
Premium
Ratings
Repligen’s Growth Potential: A Buy Rating Backed by Innovation and Strategic Positioning
3M ago
Repligen announces strategic partnership with Novasign
PremiumThe FlyRepligen announces strategic partnership with Novasign
5M ago
Repligen’s Strong Market Position and Growth Prospects Justify Buy Rating
Premium
Ratings
Repligen’s Strong Market Position and Growth Prospects Justify Buy Rating
5M ago
Repligen’s Earnings Call Highlights Robust Growth
Premium
Company Announcements
Repligen’s Earnings Call Highlights Robust Growth
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100